China’s 2008 Top 10 TCM News
This article was originally published in PharmAsia News
Executive Summary
China's State Administration of Traditional Chinese Medicine has picked the top 10 TCM news events of 2008
You may also be interested in...
China Dedicated RMB 3.5 Billion For TCM Development In 2008
China's National Development and Reform Commission, Ministry of Finance and Ministry of Science and Technology allocated funds of more than RMB 3.5 billion ($512.36 million) in 2008 to support traditional Chinese medicine development. The unprecedented financial support in terms of strength and scope covers health care, education, research, culture and infrastructure establishment of TCM hospitals. Of the amount, RMB 31 million ($4.53 million) came from central finance for an innovative program to publicize and popularize TCM knowledge nationwide. Recently, NDRC and the State Administration of Traditional Chinese Medicine jointly identified 16 key TCM clinical research areas for development. With investment of more than RMB 4 billion ($585 million), the project is scheduled to begin in 2009. The increased funding seeks to accelerate changes in TCM fundamentals and innovation. (Click here for more - Chinese Language)
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.